Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis

<br><strong>Background: </strong>Gatifloxacin is used for the treatment of multidrug-resistant tuberculosis (MDR-TB). The optimal dose is unknown.</br> <br><strong>Methods: </strong>We performed a 28-day gatifloxacin hollow-fiber system model of tuberculosi...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Deshpande, D, Pasipanodya, JG, Srivastava, S, Bendet, P, Koeuth, T, Bhavnani, SM, Ambrose, PG, Smythe, W, McIlleron, H, Thwaites, GE, Gumusboga, M, Van Deun, A, Gumbo, T
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: Oxford University Press 2018

Benzer Materyaller